PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Athira Pharma, Inc. (ATHA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS04746L1044
CUSIP04746L104
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$97.73M
EPS-$3.09
EBITDA (TTM)-$126.13M
Year Range$1.33 - $4.30
Target Price$7.42
Short %2.79%
Short Ratio2.71

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ATHA

Athira Pharma, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Athira Pharma, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%OctoberNovemberDecember2024FebruaryMarch
-83.99%
58.29%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Athira Pharma, Inc. had a return of 12.76% year-to-date (YTD) and 15.61% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date12.76%10.16%
1 month-31.67%3.47%
6 months37.00%22.20%
1 year15.61%30.45%
5 years (annualized)N/A13.16%
10 years (annualized)N/A10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202430.45%21.45%
2023-23.63%-9.42%-22.77%-7.69%68.75%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Athira Pharma, Inc. (ATHA) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ATHA
Athira Pharma, Inc.
0.29
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Athira Pharma, Inc. Sharpe ratio is 0.29. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
0.29
2.79
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Athira Pharma, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-92.01%
0
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Athira Pharma, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Athira Pharma, Inc. was 95.95%, occurring on Nov 9, 2023. The portfolio has not yet recovered.

The current Athira Pharma, Inc. drawdown is 92.01%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.95%Dec 24, 2020724Nov 9, 2023
-14.9%Oct 21, 20206Oct 28, 20205Nov 4, 202011
-13.58%Nov 16, 20208Nov 25, 202010Dec 10, 202018
-10.73%Oct 1, 20202Oct 2, 202011Oct 19, 202013
-10%Nov 5, 20202Nov 6, 20205Nov 13, 20207

Volatility

Volatility Chart

The current Athira Pharma, Inc. volatility is 35.10%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%OctoberNovemberDecember2024FebruaryMarch
35.10%
2.80%
ATHA (Athira Pharma, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Athira Pharma, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items